In the last five years, Dana-Farber has played a foundational role in more than half the cancer drugs approved by the FDA. Dana-Farber’s revolutionary discoveries are changing #cancer treatment everywhere.

#danafarber #cancer #cancer drugs

Cancer incidence is on the rise: there’s been an 8 percent increase of breast cancer among younger women in recent yrs. Join Dana Farber’s Ann Partridge MD, MPH & @BCRF for a virtual panel, exploring the challenges young mothers face when diagnosed w/cancer: zoom.us/webinar/regist…

Runners call it Heartbreak Hill, but for Michelle O’Brien the long, rising stretch of pavement that crosses the 20-mile point of the Boston Marathon® route represents the top of the mountain.

blog.dana-farber.org/insight/2024/0…

Dana-Farber extends full support to Dr. Francis Collins, former director of the National Institutes of Health, as he publicly announces his prostate cancer diagnosis. Statement below from Toni Choueiri, MD, (Toni Choueiri, MD), Director of Dana-Farber Lank Center for Genitourinary Oncology
CC: @DanaFarber

April 16th is National Healthcare Decisions Day. A day meant to inspire, educate and empower the public and healthcare providers about the importance of advance care planning. You can learn more about services offered at Dana-Farber here: ms.spr.ly/6015c7upB

Just started! Come on down! If you are far away from #Boston , check the link to register👇

na.eventscloud.com/website/68476/

Toni Choueiri, MD Medscape Dana-Farber Lank Center for Genitourinary Oncology @DanaFarber Gustave Roussy

Elizabeth Buchbinder, MD and Lauren Desnoyers, RN meet with a patient on Yawkey 5. Dr. Buchbinder and the #CellTherapies team are preparing to offer tumor-infiltrating lymphocyte (TIL therapy), recently approved for relapsed/refractory #melanoma .

#DanaFarber

BCL2 inhibitors are drugs that prompt #cancer cells to die by altering the interactions among key proteins within the cells.

#cancer #BCL2Inhibitors

blog.dana-farber.org/insight/2024/0…

When Stephanie was diagnosed with rectal cancer, her expert care team at Dana-Farber was ready with a plan. Following treatment with immunotherapy, today the young mom is doing well, and her family is supporting research that can help more patients. blog.dana-farber.org/insight/2024/0…

“When you are going through stuff like this, you feel like you need somebody who understands,” says Robert Jenkins. “Dr. Jacobsen is always so patient. He just says, ‘This is what I’m here for.’”

blog.dana-farber.org/insight/2024/0…

LAST CALL📢
Friday, April 12 is the last day to submit abstracts to our upcoming #Cancer #Immunotherapy event in #Boston !
📜👉go.nature.com/4cebU2z

Dana-Farber Nature Cancer Nature Medicine Nature Immunology Nature Rev Immunol

“Walk day is special for both of us, especially the monumental event of crossing the finish line. It’s a very emotional moment, filled with tears of sadness for those who are no longer with us, but also tears of happiness for all the cancer survivors. It’s an…

The Dana-FarberYAProgram is hosting their Annual Young Adult Cancer Conference on Saturday, April 20th at @DanaFarber for people treated for a cancer or a blood disorder as a young adult and their caregivers. Click the link below to register!
redcap.partners.org/redcap/surveys…

Join Dana-Farber's Dr. Jennifer Chan as she co-hosts the NANETS Multidisciplinary Management of NET Disease Medical Education Conference for health professionals on Saturday, May 4 7:30 am-3:30 pm.

Learn more and register here: nanets.net/NEWENGLAND

#neuroendocrinetumor

Join us 5/10 for the Annual Cancer Disparities Research Symposium!

Hosted by Christopher Lathan, MD, MS, MPH, & Karen Burns White, it will focus on Equity in Clinical Trials Participation in recognition of National Minority Cancer Awareness.

ms.spr.ly/6016cxYAY

I was a regular smoker and I quit. How can I reduce my cancer risk?

It's a common question that we're answering with the help of David Jackman, MD, senior physician at Dana-Farber Cancer Institute.

#cancerprevention #cancerscreening #oncology #doctor #lungs #carcinoma

#LungCancer data at #AACR24 : Dana-Farber's Pasi Jänne, MD, PhD, reports on ctDNA with an EGFR mutation in FLAURA2 trial. The new data shows patients whose blood tested positive before therapy for tumor cell DNA with EGFR mutations stood to gain the most from combination therapy.

Christopher Fletcher, MD, Dana-Farber has received the #AACR24 James S. Ewing-Thelma B. Dunn Award for Outstanding Achievement in Pathology in Cancer Research for discoveries transforming the cancer pathology field and establishing innovative therapies.

ms.spr.ly/6017c4cES

Vici Robinson was adamant that she wanted to “be with the best physicians,” so she decided to come to Dana-Farber Brigham Cancer Center all the way from her home an hour south of the Canadian border.

blog.dana-farber.org/insight/2024/0…

Tips on talking to children about a cancer diagnosis - Dana-Farber's Toni Choueiri, MD, (@DrChoueiri) and Max McMahon, LICSW, discuss in TIME having the conversations and how diagnosis and treatment can impact the entire family.

CC: Dana-Farber_GU

ms.spr.ly/6010c460C